Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M708870200 on November 21, 2007

J. Biol. Chem., Vol. 283, Issue 5, 2927-2938, February 1, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/5/2927    most recent
M708870200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, B.
Right arrow Articles by Basi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, B.
Right arrow Articles by Basi, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Identification of {gamma}-Secretase Inhibitor Potency Determinants on Presenilin*Formula

Byron Zhao1, Mei Yu, Martin Neitzel, Jennifer Marugg, Jacek Jagodzinski, Mike Lee, Kang Hu, Dale Schenk, Ted Yednock, and Guriqbal Basi2

From the Elan Pharmaceuticals Inc., South San Francisco, California 94080

Production of amyloid β peptides (Aβ), followed by their deposition in the brain as amyloid plaques, contributes to the hallmark pathology of Alzheimer disease. The enzymes responsible for production of Aβ, BACE1 and {gamma}-secretase, are therapeutic targets for treatment of Alzheimer disease. Two presenilin (PS) homologues, referred to as PS1 and PS2, comprise the catalytic core of {gamma}-secretase. In comparing presenilin selectivity of several classes of {gamma}-secretase inhibitors, we observed that sulfonamides in general tend to be more selective for inhibition of PS1-comprising {gamma}-secretase, as exemplified by ELN318463 and BMS299897. We employed a combination of chimeric constructs and point mutants to identify structural determinants for PS1-selective inhibition by ELN318463. Our studies identified amino acid residues Leu172, Thr281, and Leu282 in PS1 as necessary for PS1-selective inhibition by ELN318463. These residues also contributed in part to the PS1-selective inhibition by BMS299897. Alanine scanning mutagenesis of areas flanking Leu172, Thr281, and Leu282 identified additional amino acids that affect inhibitor potency of not only these sulfonamides but also nonsulfonamide inhibitors, without affecting Aβ production and presenilin endoproteolysis. Interestingly, many of these same residues have been identified previously to be important for {gamma}-secretase function. These findings implicate TM3 and a second region near the carboxyl terminus of PS1 aminoterminal fragment in mediating the activity of {gamma}-secretase inhibitors. Our observations demonstrate that PS-selective inhibitors of {gamma}-secretase are feasible, and such inhibitors may allow differential inhibition of Aβ peptide production and Notch signaling.


Received for publication, October 29, 2007

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1-S3.

1 Present address: 819 Epperson Way, Sugar Land, TX 77479.

2 To whom correspondence should be addressed: Elan Pharmaceuticals Inc., 700 Gateway Blvd., S. San Francisco, CA 94080. Tel.: 650-877-0900; Fax: 650-877-7615; E-mail: guriq.basi{at}elan.com.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Protein Eng Des SelHome page
R. Robert, O. Dolezal, L. Waddington, M. K. Hattarki, R. Cappai, C. L. Masters, P. J. Hudson, and K. L. Wark
Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers
Protein Eng. Des. Sel., March 1, 2009; 22(3): 199 - 208.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Tolia, K. Horre, and B. De Strooper
Transmembrane Domain 9 of Presenilin Determines the Dynamic Conformation of the Catalytic Site of {gamma}-Secretase
J. Biol. Chem., July 11, 2008; 283(28): 19793 - 19803.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Y. Ma, E. W Rubel, and D. W. Raible
Notch Signaling Regulates the Extent of Hair Cell Regeneration in the Zebrafish Lateral Line
J. Neurosci., February 27, 2008; 28(9): 2261 - 2273.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement